News | October 30, 2013

Private Hospital Group in Spain Expands Radiotherapy Capabilities with Country's First Elekta Versa HD System

HM hospitales spain radiation therapy elekta versa hd mosaiq
October 30, 2013 — HM Hospitales, a private hospital group in Spain, anticipates treating its first patients with Elekta's Versa HD system in 2015. 
 
Versa HD, to be sited in the group's sixth hospital, is a radiation treatment system designed to enhance the management of cancer care and treat a broad spectrum of tumors throughout the body. It is a single-system linear accelerator capable of delivering conventional therapies for an expansive range of indications commonly seen in the clinic while also permitting treatment of complex cancers that require exceptional targeting accuracy.
 
"Versa HD will allow us to treat patients with the most modern radiation therapy techniques, from traditional treatments to radiosurgery procedures," said Juan Abarca Cidon, M.D., general manager, HM Hospitales. "We will use Versa HD for virtually all cancer pathologies located throughout the body. The system's High Dose Rate mode and ultra-fast and precise Agility beam shaping capabilities also will improve the speed with which we can deliver therapy, which will improve patient comfort through shorter treatment times."
 
The new medical center, Hospital HM Universitario Puerto del Sur, will be connected to the hospital group's first radiation oncology department — Clara Campal Comprehensive Cancer Center, HM Sanchinarro — via Elekta's Mosaiq Oncology Information System (OIS). It will replace the Siemens Lantis OIS that had been in use at the cancer center.
 
"The Puerto del Sur clinic will serve an area of approximately one million inhabitants in the area south of Madrid," said Cidon. "It is important that we provide cancer patients in Mostoles and the wider region with access to the very latest treatment technology."
 
For more information: www.versahd.com, www.elekta.com
 

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...